Patent Expiry
DERM: ZILXI: recorded patent 10213512 expiry
October 1, 2030 · MINOCYCLINE HYDROCHLORIDE. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- October 1, 2030
- Company
- Journey Medical Corp (DERM)
- Drug
- MINOCYCLINE HYDROCHLORIDE
BioSniper AIPage context preserved
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Patent Expiry
ZILXI: recorded patent 10213512 expiry
Orange Book application NDA213690, product 001, listed patent 10213512 expiry. Overall loss of exclusivity and current company rights: unknown.FDA source